24 results
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
Board and Cancer Research Executive Team. Prior to GlaxoSmithKline, Dr. Bolno served as Director of Research at Two River LLC, a health care private
S-3
EX-1.2
SQZB
SQZ Biotechnologies Co
12 Nov 21
Shelf registration
12:00am
, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) to conduct the studies that are described in, or the results … other “at the market” or continuous equity transaction.
(uu) Compliance with Health Care Laws. Except as would not, individually or in the aggregate
DEF 14A
cigxg6cqe26ay47
26 Apr 21
Definitive proxy
5:00pm
10-K
zj2 0kq24e
18 Mar 21
Annual report
6:31am
424B4
qf75rgfj
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
f4ewmqltdqv3 j7ks9
1 Feb 21
Draft registration statement
12:00am
10-Q
4ue2 5csrc9bimu9ny
10 Dec 20
Quarterly report
4:46pm
424B4
26hywcd
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
kc2 rl50tkgt2sh
9 Oct 20
IPO registration
4:59pm
S-1
EX-10.7
v6xzg
9 Oct 20
IPO registration
4:59pm
DRS/A
r4s6l46
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
mz3v eh0kn
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
ec7fbo04q kv4
28 Aug 20
Draft registration statement (amended)
12:00am